Filter
673
Filtered Results: 673
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
64
New Publications
203
Language
Document type
No document type
347
Studies & Reports
123
Guidelines
100
Manuals
40
Strategic & Response Plan
40
Training Material
9
Fact sheets
9
Situation Updates
3
Resource Platforms
2
Countries / Regions
India
35
Global
34
Kenya
31
Ethiopia
26
South Africa
16
Uganda
16
Western and Central Europe
13
Nepal
11
Tanzania
11
Liberia
11
Sierra Leone
10
Nigeria
10
Philippines
10
Ghana
9
Namibia
9
Zambia
9
Rwanda
8
Ukraine
7
Bangladesh
7
Myanmar / Burma
7
Zimbabwe
6
Africa
6
Indonesia
6
Syria
5
South Sudan
5
Lesotho
4
Malawi
4
Cambodia
4
Congo, Democratic Republic of
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Cameroon
3
Senegal
3
South–East Asia Region
3
Eswatini/ Swaziland
3
Thailand
2
Fiji
2
Laos
2
Burkina Faso
2
Mozambique
2
Asia
2
Latin America and the Carribbean
2
Jordan
2
West and Central Africa
2
Vietnam
2
Botswana
2
Pakistan
2
Timor Leste/ East Timor
1
Australia
1
Benin
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Guinea
1
USA
1
Haiti
1
Lithuania
1
Belgium
1
United Kingdom
1
East and Southern Africa
1
Lebanon
1
Brazil
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
278
Key Resources
42
Clinical Guidelines
38
Public Health
31
Women & Child Health
21
Pharmacy & Technologies
9
Capacity Building
8
Toolboxes
Pharmacy
65
AMR
59
COVID-19
32
NTDs
30
HIV
29
Mental Health
28
TB
28
Planetary Health
28
Rapid Response
18
NCDs
17
Health Financing Toolbox
14
Conflict
13
Caregiver
11
Ebola & Marburg
9
Global Health Education
9
Specific Hazards
6
Disability
5
Refugee
3
Natural Hazards
3
Social Ethics
2
South Sudan
1
Zika
1
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analysis, and Phase IV studies. Before new interventions...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
This implementation guide has been developed to help birth attendants and health-care leaders successfully launch and sustain use of the WHO Safe Childbirth Checklist. Development, use and implementation of the Checklist are described in this guide.
It covers how to introduce and ensure continuous ...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Towards the Peoples Health Assembly Book -2
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp...
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttrau...
Comment réussir à demander, administrer et gérer les dons de Zithromax® pour l’élimination du trachome
